BLRX
BioLineRx·NASDAQ
--
--(--)
--
--(--)
4.44 / 10
Netural
Money flow evaluation scores 7.34/10, reflecting robust inflows, particularly at the small and large scales, despite overall block-level weakness. This positive fund-flow trend contrasts with the subdued analyst sentiment, which is overwhelmingly bullish (Strong Buy at 100%) yet historically inconsistent. The divergence between strong money inflows and lukewarm analyst support adds complexity to the current market position.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-06-17
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate33.3%
What is the market sentiment for BLRX?
- BLRX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.44/10 (Netural).
